BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36157032)

  • 1. Heparanase in cancer progression: Structure, substrate recognition and therapeutic potential.
    Yuan F; Yang Y; Zhou H; Quan J; Liu C; Wang Y; Zhang Y; Yu X
    Front Chem; 2022; 10():926353. PubMed ID: 36157032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential roles of heparanase in cancer therapy: Current trends and future direction.
    Yang Y; Yuan F; Zhou H; Quan J; Liu C; Wang Y; Xiao F; Liu Q; Liu J; Zhang Y; Yu X
    J Cell Physiol; 2023 May; 238(5):896-917. PubMed ID: 36924082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Overview of the Structure, Mechanism and Specificity of Human Heparanase.
    Wu L; Davies GJ
    Adv Exp Med Biol; 2020; 1221():139-167. PubMed ID: 32274709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian heparanase: what is the message?
    Vreys V; David G
    J Cell Mol Med; 2007; 11(3):427-52. PubMed ID: 17635638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparanase: Historical Aspects and Future Perspectives.
    Khanna M; Parish CR
    Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial purification of heparanase activities in Chinese hamster ovary cells: evidence for multiple intracellular heparanases.
    Bame KJ; Hassall A; Sanderson C; Venkatesan I; Sun C
    Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):191-200. PubMed ID: 9806900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of heparanase inhibitors for anti-cancer therapy.
    Miao HQ; Liu H; Navarro E; Kussie P; Zhu Z
    Curr Med Chem; 2006; 13(18):2101-11. PubMed ID: 16918340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.
    Barash U; Cohen-Kaplan V; Dowek I; Sanderson RD; Ilan N; Vlodavsky I
    FEBS J; 2010 Oct; 277(19):3890-903. PubMed ID: 20840586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-D-glucuronidase (heparanase).
    Gandhi NS; Freeman C; Parish CR; Mancera RL
    Glycobiology; 2012 Jan; 22(1):35-55. PubMed ID: 21746763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Good and Bad Sides of Heparanase-1 and Heparanase-2.
    Pinhal MAS; Melo CM; Nader HB
    Adv Exp Med Biol; 2020; 1221():821-845. PubMed ID: 32274740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of heparanase from a rat parathyroid cell line.
    Podyma-Inoue KA; Yokote H; Sakaguchi K; Ikuta M; Yanagishita M
    J Biol Chem; 2002 Sep; 277(36):32459-65. PubMed ID: 12077130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of heparanase by HPV E6 oncogene in head and neck squamous cell carcinoma.
    Hirshoren N; Bulvik R; Neuman T; Rubinstein AM; Meirovitz A; Elkin M
    J Cell Mol Med; 2014 Jan; 18(1):181-6. PubMed ID: 24286246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.
    Jia L; Ma S
    Eur J Med Chem; 2016 Oct; 121():209-220. PubMed ID: 27240275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold Standard.
    Chhabra M; Ferro V
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30441818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that platelet and tumour heparanases are similar enzymes.
    Freeman C; Browne AM; Parish CR
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):361-8. PubMed ID: 10455023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of heparanase and the tumor microenvironment on cancer metastasis and angiogenesis: basic aspects and clinical applications.
    Vlodavsky I; Elkin M; Ilan N
    Rambam Maimonides Med J; 2011 Jan; 2(1):e0019. PubMed ID: 23908791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing of potential glycan-based heparanase inhibitors in a fluorescence activity assay using either bacterial heparinase II or human heparanase.
    Schoenfeld AK; Vierfuß S; Lühn S; Alban S
    J Pharm Biomed Anal; 2014 Jul; 95():130-8. PubMed ID: 24667567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases.
    Rivara S; Milazzo FM; Giannini G
    Future Med Chem; 2016 Apr; 8(6):647-80. PubMed ID: 27057774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular properties and involvement of heparanase in cancer progression and normal development.
    Vlodavsky I; Goldshmidt O; Zcharia E; Metzger S; Chajek-Shaul T; Atzmon R; Guatta-Rangini Z; Friedmann Y
    Biochimie; 2001 Aug; 83(8):831-9. PubMed ID: 11530216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development.
    Vlodavsky I; Goldshmidt O; Zcharia E; Atzmon R; Rangini-Guatta Z; Elkin M; Peretz T; Friedmann Y
    Semin Cancer Biol; 2002 Apr; 12(2):121-9. PubMed ID: 12027584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.